Group items tagged

The Eardoc was tested in the Top Medical University in Europe. The test was performed with a Tympanometer on 40 Patients over six weeks, it showed with no doubt that the EARDOC opens the Eustachian tube and relieves the pain.

The A1C test is a blood test that shows your blood sugar levels over the past two to three months and this helps in evaluating whether you are suffering from diabetes.

Get your thyroid test done from best path lab of Delhi NCR, Lifeline Laboratory. We provide home collection service in delhi NCR with the accurate report within a day

The only way to know for sure whether you have HIV is to get tested. You can ask your health care provider for an #HIV test. Many #medical clinics, community health centers, and hospitals offer them too. You can also get an HIV test from our clinic just visit our website and book your appointment: https://www.drpounders.com/ or Call Us on 214-520-8833

National Institute for Health and Care Excellence (NICE)'s diagnostic advisory committee has recommended the use of HM-JACKarc or OC-Sensor quantitative faecal immunochemical tests (FIT) in a draft guidance release for consultation on Wednesday (5 July). Under existing NICE guidance, FIT was already offered to some people presenting to primary care with symptoms suggestive of colorectal cancer, while others were immediately referred on the suspected cancer pathway. The new draft guidance will now see everyone receive a FIT. A sample is sent in the post to a laboratory where the amount of blood in the faeces is measured. The results are usually available within a week and people with 10 or more micrograms of haemoglobin in their faeces should then be referred for further investigation. Further assessment using colonoscopy, or CT colonography, is required to diagnose cancer. The tests cost between £4 and £5 per sample, and can correctly identify about 9 out of 10 people with colorectal cancer. The committee agreed it is important that GPs can refer people for colonoscopy without a positive FIT result if they think it is necessary and where symptoms persist. The institute believes that the recommendation of the tests should reduce the number of unnecessary colonoscopies, thus freeing up appointments for more non-urgent referrals. This should lead to 50% fewer referrals for urgent colonoscopies being made by GPs in primary care settings each year.

A pharmacy assistant has been jailed for three years and seven months for stealing £330,000 worth of diabetes-testing kits from his workplace. Abdul Nargoliya stole the products while working as a pharmacy assistant at a Lloydspharmacy counter inside a Sainsbury's supermarket in Fosse Park, Leicester where we was employed since 2012. The 30-year-old from Woodboy Street in Leicester was sentenced on Friday (May 26) after pleading guilty at Leicester Crown Court "to theft by an employee and concealing, transferring, converting criminal property". According to police an internal investigation launched at the pharmacy branch in July 2018 revealed that more than 22,000 test kits had been ordered since January 2017. Leicester Police said they identified Nargoliya as a suspect due to the time of the orders being placed matching up to his shift patterns. They arrested him in July 2018. Orders for the products were placed by telephone and CCTV footage showed Nargoliya handling them. It was noticed that during his shifts, the defendant would move the deliveries into a private consultation room and later leave with full carrier bags.

The NHS staff delivered more than 25 million checks for patients' which is almost 2 million more than before the pandemic. There has been an increase of almost 50 per cent between August to July as compared to a decade ago. In 2013, the figures saw 11 million life-saving tests and checks being conducted by NHS staff in the same period. Amanda Pritchard, NHS chief executive applauded the hard work of staff for delivering two more million tests and checks in the last year. She said: "NHS campaigns encouraging people to come forward with worrying signs are having a hugely positive effect, with thousands more patients getting checked - so as ever, if you have any health concerns, please do get checked - it could save your life".

NHS England has expanded its national bowel screening programme to people aged 54 so that cancers can be detected at an earlier stage when they are easier to treat. As part of the expansion, the health service would be sending a home-testing kit for bowel cancer, known as the Faecal Immunochemical Test (FIT), to thousands more people in the North West. Those who are eligible (aged 54 and over) will now automatically receive the kit every two years by post, enabling them to self-check for blood in stool samples, which can be a sign of bowel cancer. With the expansion of the NHS Bowel Cancer Screening Programme to people aged 54 years, an additional 830,000 people in England will now be eligible for the screening test.

Regular health screenings are an essential part of maintaining wellness, and one vital test for women is the Pap smear. Known for its role in early detection of cervical cancer, the Pap smear is a simple yet powerful tool that can potentially save lives. In this blog, we will explore the significance of Pap smears, what the procedure involves, and how often you should get tested. The Importance of Regular Local Screenings Staying on top of your health requires vigilance, and regular local screenings play an indispensable role in this effort. Local screenings, like Pap smears, are essential in detecting potential health issues at their earliest stages, making treatments more effective and improving outcomes. By participating in these routine checks, you not only safeguard your health but also contribute to broader public health efforts by identifying and addressing potential outbreaks or health trends within the community. Whether that's HPV and Pap tests in Singapore or a mammogram in the US, local screenings are crucial for maintaining overall wellness. This is especially true for Pap smears, as they play a significant role in detecting and preventing cervical cancer.

  North Korea tested a Musudan missile, which is capable of hitting US bases as far away as Guam. Seoul: An outburst almost immediately after takeoff was behind the failure of North Korea’s latest test-firing of a powerful medium-range missile, the South Korean military established on Monday. North Korea tested a Musudan missile - which ...

We offer the full range of blood test at home with results available as early as 48 hours. Mobile Phlebotomy offered for blood sample collection.

Know the importance of HIV Testing Day and raise awareness and support people to suffer form HIV positive with customized rubber bracelets.

The minimum Covid-19 self-isolation period in England will be cut to five days from seven if someone tests negative twice, health secretary Sajid Javid said on Thursday (January 13) - a move that could reduce staffing disruption in businesses and infrastructure. The rapid spread of the Omicron variant has fuelled a spike in Covid-19 cases to record highs in Britain, and the surge has cause major disruption to the staffing of hospitals, schools and transport as staff have to self-isolate. "We've made the decision to reduce the minimum self-isolation period to five full days in England," Javid told parliament. "From Monday, people can test twice before they go, leaving isolation at the start of day six." The government had previously reduced isolation period to seven days from 10 days to people in England who get a negative result on a rapid lateral flow test two days in a row.

GlaxoSmithKline (GSK) says initial tests of the antibody-based Covid-19 therapy it is developing with US partner Vir suggest the drug is effective against the Omicron variant. A GSK statement on Thursday (December 2) said that lab tests and a study on hamsters have demonstrated the sotrovimab antibody cocktail to work against viruses that were bio-engineered to carry a number of hallmark mutations of the new variant. The tests are continuing to confirm the results against all of the Omicron mutations, with an update expected by the end of the year, it added. The antibody is designed to latch on to the spike protein on the surface of the coronavirus, but Omicron has been found to have an unusually high amount of mutations on that protein. "Sotrovimab was deliberately designed with a mutating virus in mind," said Vir chief executive George Scangos, adding that the drug was targeting a region of the spike protein that was highly unlikely to mutate.

Researchers from the University of Oxford today (December 8) started recruiting for a clinical trial to test novel antiviral Covid-19 treatments for early use in the illness by people in the community and those who are at higher risk of complications. Partnering with the National Institute for Health Research (NIHR), colleagues in several UK universities, and the NHS UK-wide, the Platform Adaptive trial of NOvel antiviRals for eArly treatMent of Covid-19 In the Community (PANORAMIC), is a national priority trial, and will be open to participants from across the UK. The first treatment to be tested by the UK Antiviral Taskforce will be molnupiravir, a Covid antiviral pill already licensed by the MHRA. Britain became the first country in the world to approve molnupiravir, which was jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics, in November.

Health authorities in India have launched an inquiry into an allegation that a local pharmaceutical regulator, in return for a bribe, helped switch samples of cough syrups that the World Health Organization (WHO) had linked to the deaths of children in Gambia before the samples were tested at an Indian laboratory, according to two government officials and documents reviewed by the Reuters news agency. In an April 29 letter to the Anti-Corruption Bureau (ACB) in Haryana state reviewed by the news agency, a lawyer named Yashpal accused the state's drug controller, Manmohan Taneja, of taking a bribe of 50 million rupees (£481,600 approx.) from local manufacturer Maiden Pharmaceuticals to help it switch the samples before an Indian government laboratory tested them. Maiden's factory is based in Haryana state. Reuters points out that it was unable to independently establish that any bribes were paid. Taneja did not respond to phone calls, messages or emails seeking comment. Maiden did not respond to requests for comment. The WHO said it had no knowledge of the allegation. Yashpal - who like some Indians uses only one name - did not say in the letter where he got the information, or provide evidence for his claim about the syrups made by Maiden. Reuters was unable to independently establish that any bribes were paid.

The UK Health Security Agency (UKHSA) and the Office for National Statistics (ONS) will jointly launch a new study to gather data on COVID-19 this winter. The Winter COVID-19 Infection Study (WCIS) will run from November 2023 to March 2024, involving up to 200,000 participants, UKHSA has said on Monday (October 2). UKHSA previously commissioned the Coronavirus Infection Survey (CIS), conducted by the ONS in collaboration with scientific study leaders from Oxford University, analysing more than 11.5 million swab tests and 3 million blood tests from April 2020 to March 2023. Meanwhile, the Winter CIS study involves conducting up to 32,000 lateral flow tests weekly, providing vital insights into COVID-19 prevalence in the broader community. The sample will be structured to broadly reflect key population characteristics.

Labour Party leader Keir Starmer leader has tested positive for Covid-19 for a second time, a spokesperson confirmed on Wednesday (January 5). Starmer had been due to face prime minister Boris Johnson at a question and answer session in parliament later today. His deputy, Angela Rayner, will take his place, the spokesperson added. Starmer had tested positive for Covid-19 last October and self-isolated four times after coming into contact with other positive cases on several occasions.